title: Alcoholic hypogonadism: hormonal response to clomiphene.
abstract: To investigate the androgen, weak androgen, estrogen, and gonadotrophin response to clomiphene in alcoholics, we determined in 63 male patients (25 with and 38 without liver cirrhosis) serum testosterone, sexual hormone binding protein (SHBG), dehidroepiandrosterone, androstenedione, LH, FSH, prolactin, and estradiol levels, on the first and the sixth day after admission, and after a course of 8 days of clomiphene 200 mg/day. The same test was performed on 15 healthy volunteers. Cirrhotic patients showed decreased basal testosterone levels and a loss of the circadian rhythm with recovery after clomiphene. Although basal testosterone levels in noncirrhotic alcoholics did not differ from those of the controls, there was a significant improvement after withdrawal. SHBG levels were higher in both groups of alcoholics than in controls, pointing to a worse degree of hypogonadism, because only the free hormone is active. Before the clomiphene test, serum LH and FSH levels were nonsignificantly higher in both groups of alcoholics than in the control group. After clomiphene both LH and FSH increased. Androstenedione and estradiol showed a (parallelism) similar behavior in alcoholic and in cirrhotic groups, showing in both cases higher levels than in the control group, and an increase after clomiphene, perhaps reflecting peripheral conversion of androgens to estrogens. Because clomiphene has no effect on the adrenal cortex, the increase of androstenedione after clomiphene points to its testicular origin (directly or after testosterone conversion) and not to an adrenal one. The highest serum estradiol levels were observed in cirrhotics with ascites or gynecomastia. We have not found any relation between serum hormone levels and alcohol intake nor with nutritional status.
authors.affiliation: Servicio de Medicina Interna, Hospital Universitario de Canarias, La Laguna, Canary Islands, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Martínez-Riera
authors.forename: F
authors.initials: F
authors.lastname: Santolaria-Fernández
authors.forename: E
authors.initials: E
authors.lastname: González Reimers
authors.forename: A
authors.initials: A
authors.lastname: Milena
authors.forename: J L
authors.initials: JL
authors.lastname: Gómez-Sirvent
authors.forename: F
authors.initials: F
authors.lastname: Rodríguez-Moreno
authors.forename: I
authors.initials: I
authors.lastname: González-Martín
authors.forename: E
authors.initials: E
authors.lastname: Rodríguez-Rodríguez
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000150:complications*; D013734:Androgen-Insensitivity Syndrome / Q000209:etiology; D000728:Androgens / Q000097:blood; D000735:Androstenedione / Q000097:blood; D002996:Clomiphene / Q000494:pharmacology*; D004958:Estradiol / Q000097:blood; D006801:Humans; D007006:Hypogonadism / Q000097:blood / Q000209:etiology*; D008104:Liver Cirrhosis, Alcoholic / Q000097:blood / Q000150:complications; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009752:Nutritional Status; D013739:Testosterone / Q000097:blood
chemical_list: D000728:Androgens; D002996:Clomiphene; D013739:Testosterone; D000735:Androstenedione; D004958:Estradiol